Effect of extended adjuvant endocrine therapy with letrozole (L) in postmenopausal women with hormone-receptor (+) breast cancer after prior adjuvant therapy with an aromatase inhibitor (AI): NRG Oncology/NSABP B-42. (March 2017) - Mamounas, E.; Bandos, H.; Lembersky, B.; Geyer, C.; Geyer, C.; Fehrenbacher, L.; Graham, M.; Paik, S.; Swain, S.; Wickerham, L.; Wolmark, N.